Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FY22T
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,943
Award facts
- Contract value 100% obligated
- $6,943.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $6,943.10, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nexplanon 68 mg implants. The contract was awarded on August 13, 2025, with an ultimate completion date of September 4, 2025, and carries a firm fixed-price structure with no set-aside designation. The Defense Logistics Agency, a defense-oriented federal purchasing organization, issued this delivery order to support pharmaceutical supply requirements for military healthcare facilities.
This award represents a delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at $499,999,999 and valid through November 2026. This IDC enables the agency to procure a comprehensive range of pharmaceutical products, including prescription medications, biologics, and medical consumables across multiple categories to support Department of Defense healthcare operations. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts with the Defense Logistics Agency to deliver specialized medical products, including contraceptive devices, oncology treatments, and other prescription pharmaceuticals to military health facilities nationwide.
Quick answers
Who was awarded contract SPE2DB25FY22T?
SPE2DB25FY22T was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 13, 2025.
How much is contract SPE2DB25FY22T worth?
The government has obligated $6,943 on SPE2DB25FY22T.
Is contract SPE2DB25FY22T an order under another contract?
Yes. SPE2DB25FY22T is a delivery order under SPE2DB22D9362, an indefinite delivery contract.
Was contract SPE2DB25FY22T competed?
The extent of competition for SPE2DB25FY22T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award